Quantbot Technologies LP Alnylam Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

A detailed history of Quantbot Technologies LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 204 shares of ALNY stock, worth $49,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares

204

Previous 11 1754.55%

Holding current value

$49,623

Previous $2,000 2700.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $45,125 - $55,392	193 Added 1754.55%	204 $56,000
Q2 2024 Aug 09, 2024	SELL	$143.31 - $247.0 $60,620 - $104,481	-423 Reduced 97.47%	11 $2,000
Q1 2024 May 06, 2024	BUY	$146.51 - $198.2 $16,848 - $22,793	115 Added 36.05%	434 $64,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $48,299 - $62,705	319 New	319 $61,000
Q2 2023 Aug 08, 2023	BUY	$185.01 - $212.05 $129,321 - $148,222	699 New	699 $132,000
Q3 2022 Nov 07, 2022	BUY	$138.54 - $232.0 $94,068 - $157,528	679 New	679 $135,000
Q2 2022 Aug 09, 2022	SELL	$120.42 - $169.29 $458,318 - $644,317	-3,806 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $484,047 - $661,901	3,806 New	3,806 $621,000
Q3 2021 Nov 09, 2021	SELL	$169.75 - $207.73 $452,214 - $553,392	-2,664 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $342,670 - $471,234	2,664 New	2,664 $451,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $151,130 - $180,663	-1,229 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $135,975 - $185,679	1,122 Added 1048.6%	1,229 $178,000
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $2,813 - $4,223	27 Added 33.75%	107 $15,000
Q1 2020 May 13, 2020	SELL	$93.12 - $133.99 $6,890 - $9,915	-74 Reduced 48.05%	80 $8,000
Q4 2019 Feb 10, 2020	SELL	$74.51 - $124.23 $3,352 - $5,590	-45 Reduced 22.61%	154 $17,000
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $92,240 - $114,253	-1,301 Reduced 86.73%	199 $16,000
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $98,790 - $139,185	1,500 New	1,500 $108,000
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $29,104 - $37,380	-400 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$62.67 - $88.33 $21,683 - $30,562	-346 Reduced 46.38%	400 $29,000
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $65,289 - $91,511	746 New	746 $65,000
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $236,847 - $289,119	-2,682 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$115.92 - $148.54 $310,897 - $398,384	2,682 New	2,682 $319,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Alnylam Pharmaceuticals, Inc. Transaction History